How many insider trades does FilingIQ track for MLTX?

FilingIQ tracks 125 Form 4 insider transactions for MLTX (MoonLake Immunotherapeutics), covering filings from Apr 5, 2022 onwards. 9 of those were filed in the last 90 days.

Are MLTX insiders net buyers or net sellers?

Across the full Form 4 history for MLTX, 38 transactions (30%) were open-market purchases and 46 (37%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does MLTX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is MLTX in?

MoonLake Immunotherapeutics (MLTX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.29B.

MLTX insider trading

NasdaqCM Healthcare

MoonLake Immunotherapeutics — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

125

Last 90 days

Buys / sells

30% / 37%

Market cap

$1.29B

About MoonLake Immunotherapeutics

MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases in dermatology and rheumatology, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.

Company website: www.moonlaketx.com

MLTX insider activity at a glance

FilingIQ has scored 125 insider transactions for MLTX since Apr 5, 2022. The most recent filing in our index is dated May 11, 2026.

Across the full history, 38 open-market purchases and 46 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on MLTX insider trades is 52.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live MLTX trades on FilingIQ Raw filings on SEC EDGAR

Latest MLTX Form 4 filings

Santos da Silva Jorge Chief Executive Officer

S Apr 10, 2026

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding MLTX

Logos Global Management LP

$32.98M · 2.7% of AUM

Frequently asked

How many insider trades does FilingIQ track for MLTX?: FilingIQ tracks 125 Form 4 insider transactions for MLTX (MoonLake Immunotherapeutics), covering filings from Apr 5, 2022 onwards. 9 of those were filed in the last 90 days.
Are MLTX insiders net buyers or net sellers?: Across the full Form 4 history for MLTX, 38 transactions (30%) were open-market purchases and 46 (37%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does MLTX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is MLTX in?: MoonLake Immunotherapeutics (MLTX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.29B.

Methodology & sources

Every MLTX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.